FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3905111000001107: Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26512501000001112 Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
66021601000001116 Molipaxin 50mg/5ml oral liquid (Sanofi) 120 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Is a Trazodone 50mg/5ml oral solution sugar free 120 ml true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Is pack of Molipaxin 50mg/5ml oral liquid (Aventis Pharma) false Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Has active ingredient Trazodone hydrochloride false Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Has manufactured dose form Conventional release oral solution false Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Has AMP Molipaxin 50mg/5ml oral liquid (Aventis Pharma) true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Has specific active ingredient Trazodone hydrochloride true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start